Healthcare
South Africa Ramps Up Vaccinations as Foot-and‑Mouth Disease Spreads Across Provinces
The South Africa foot-and-mouth disease outbreak has extended to five provinces, prompting authorities to order over 900,000 vaccine doses and consider disaster-level response. Quarantine in major feedlots and export bans threaten the country’s cattle sector and beef exports.
Healthcare
U.S. COVID Vaccine Recommendations Cause Confusion Among Doctors and Insurers
The recent shifts in U.S. COVID vaccine recommendations by Health Secretary RFK Jr. and CDC have created confusion over who should get boosters and what insurers cover, especially for children and pregnant women. With insurers awaiting ACIP guidance ahead of the late‑June meeting, the healthcare system braces for uncertainty.
Healthcare
Brazil Bird Flu Case Ruled Out at Commercial Farm: Signs of Strong Containment
Brazil bird flu case ruled out at a commercial chicken farm in Rio Grande do Sul after extensive testing. With only one confirmed farm outbreak and strong biosecurity, the poultry sector braces for renewed exports and industry-wide resilience.
All News
Ozempic Wegovy Eye Risk: EMA Confirms Rare NAION Side Effect
The European Medicines Agency has confirmed a rare but serious Ozempic Wegovy eye risk—non-arteritic anterior ischemic optic neuropathy (NAION). Semaglutide users should be alert to vision changes and consult doctors promptly.
Innovation
AI-Powered Radiology Service Launched to Transform Cancer Detection in NHS
The new AI‑powered radiology service integrates machine learning with medical imaging across NHS sites to enhance cancer detection—from sarcoma to prostate tumors—accelerating diagnosis and empowering clinicians with reliable, AI‑driven insights.
Clinical Trials
Zepbound vs Wegovy Head-to-Head Trial: A New Benchmark in Obesity Treatment
In a landmark 72-week clinical trial, Eli Lilly's Zepbound achieved significantly greater weight loss compared to Novo Nordisk's Wegovy, marking a pivotal advancement in obesity pharmacotherapy.
All News
Accropeutics AC-201 Phase 2 Trial Shows Strong Efficacy in Psoriasis Treatment
Accropeutics’ oral TYK2/JAK1 inhibitor AC-201 has shown major efficacy in a Phase 2 trial for moderate-to-severe plaque psoriasis. The study indicates significant clinical improvements and a favorable safety profile, potentially reshaping autoimmune treatment standards.
Marketing
Indian Pharma Exports FY24 Surge 10%: A Strong Rebound Led by U.S. and EU Demand
India’s pharmaceutical exports rebounded strongly in FY24 with a 10% rise, reaching $27.9 billion. The growth was powered by U.S. and EU demand, aided by global recognition of Indian generics and supportive government initiatives. Here's what this means for the future of Indian pharma.
FDA Approvals
Lupin Generic Oracea Launch in U.S. Boosts Rosacea Care and Dermatology Market Reach
Lupin Ltd. has entered the U.S. dermatology market with the first FDA-approved generic version of Oracea, targeting rosacea treatment. This significant step boosts its presence in high-margin specialty drugs and expands access to effective rosacea therapy.
Financial
Sun Pharma Q4 Profit Soars 24% in 2025: Rare Disease Drugs Drive India’s Pharma Momentum
India’s pharma leader Sun Pharma reported a 24% profit jump in Q4 2025, fueled by rising demand for rare disease treatments and specialty drugs. While domestic performance remains strong, global challenges and innovative breakthroughs in drug development are reshaping the pharmaceutical landscape. This article explores the company’s growth, industry trends, and what the future holds for India’s pharma sector.
Innovation
Nano-Particles in Cancer Treatment: Smarter, Safer Cancer Therapy in 2025
Oregon Health & Science University has developed a nano-particle that can locate and destroy a tumor and can also help delivery chemotherapy to the tumor site.